Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)

NCT03414489 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Cholangiocarcinoma
Cholangiocarcinoma Non-resectable
Cholangiocarcinoma, Perihilar
Cholangiocarcinoma, Extrahepatic
Cholangiocarcinoma, Intrahepatic

Interventions

DRUG: ABC294640

Sponsor

RedHill Biopharma Limited